State Street Corp Oric Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,938,169 shares of ORIC stock, worth $16.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,938,169

Previous 2,256,228 14.1%

Holding current value

$16.5 Million

Previous $16 Million 24.54%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.52 - $11.9 $2.39 Million - $3.78 Million	-318,059 Reduced 14.1%	1,938,169 $19.9 Million
Q2 2024 Aug 14, 2024	BUY	$6.63 - $12.93 $3.58 Million - $6.98 Million	540,147 Added 31.48%	2,256,228 $16 Million
Q1 2024 May 15, 2024	BUY	$8.04 - $16.03 $7.42 Million - $14.8 Million	923,007 Added 116.38%	1,716,081 $23.6 Million
Q4 2023 Feb 14, 2024	BUY	$5.41 - $9.43 $400,664 - $698,385	74,060 Added 10.3%	793,074 $7.3 Million
Q3 2023 Nov 14, 2023	SELL	$6.05 - $9.28 $88,317 - $135,469	-14,598 Reduced 1.99%	719,014 $4.35 Million
Q2 2023 Aug 14, 2023	BUY	$4.95 - $8.4 $3.09 Million - $5.24 Million	623,532 Added 566.44%	733,612 $5.69 Million
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.07 $1.31 Million - $3.42 Million	-483,469 Reduced 81.45%	110,080 $493,000
Q1 2022 May 16, 2022	SELL	$4.54 - $16.1 $3.08 Million - $10.9 Million	-678,279 Reduced 53.33%	593,549 $3.17 Million
Q4 2021 Feb 14, 2022	BUY	$12.01 - $20.3 $2.55 Million - $4.3 Million	211,929 Added 20.0%	1,271,828 $18.7 Million
Q3 2021 Nov 15, 2021	SELL	$15.9 - $25.22 $3.05 Million - $4.84 Million	-192,014 Reduced 15.34%	1,059,899 $22.2 Million
Q2 2021 Aug 16, 2021	SELL	$17.37 - $25.34 $1.97 Million - $2.88 Million	-113,652 Reduced 8.32%	1,251,913 $22.1 Million
Q1 2021 May 17, 2021	BUY	$23.67 - $36.85 $23.8 Million - $37.1 Million	1,006,522 Added 280.33%	1,365,565 $33.5 Million
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $4.85 Million - $9.5 Million	238,723 Added 198.41%	359,043 $12.2 Million
Q3 2020 Nov 10, 2020	BUY	$19.5 - $31.26 $435,415 - $698,004	22,329 Added 22.79%	120,320 $3.01 Million
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $2.52 Million - $3.74 Million	97,991 New	97,991 $3.31 Million

Others Institutions Holding ORIC

# of Institutions

124

Shares Held

66.6M

Call Options Held

7.8K

Put Options Held

700

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Oric Pharmaceuticals, Inc. Transaction History